Most patients taking prescription medicine (72%) also use mobile apps (Android smartphone, iPhone, Android tablet, iPad, or Kindle Fire),
Mobile app adoption rates are high across all medication-taking adult age groups: 93% (age 18-24), 90% (age 25-34), 88% (age 35-44), 80% (age 45-54), 66% (age 55-64), and 50% (age 65+),
App-using patients prefer the privacy-protected single app Mobile Health Library (MHL) system (by a factor of 11 to 1) over email programs often offered by medication manufacturers. This high preference for a privacy-protected single app, customized to a user's needs for medication education and support services, was observed across all adult age groups.
Like most sectors, pharma periodically discovers new buzzwords and hot topics which become inescapable for 2-3 years, and begin to sound like the answer to every question. At the moment, that buzzwords is 'big data' – but while the hype can...
This summer is shaping up to be a very healthy season—if you’re a maker of digital fitness apps. Both Apple and Google are scheduled to hold their big, annual events for developers, with new programming tools for health software taking center stage.
At Apple's Worldwide Developers Conference, the star of the show seems likely to be the rumored Healthbook, a repository for biological signals—“biosignals," for short. And Google seems poised to unveil details of Android Wear, its new platform for wearable devices, at Google I/O.
There is a great deal of attention being paid to mobile health applications at the moment, especially in the context of wearable technology. For example, Samsung, Apple and even Google, have recently made clear the focus they will place on this exciting intersection of biology, medicine, healthcare and digital technology.
However, some statistics suggest 90% of health apps are deleted or not used again after 10 days, so getting it wrong can be a terrible waste of investment. From my experience, there are four key principles that tend to define if an application in healthcare will work, and if it is likely to be used:.
Another great initiative by Merck here. My question though is that the kinds of outcomes and insights we're talking about might be better managed by a more independent player! Not sure how comfortable patients are about being data-mined by a Pharma company.
As a healthtech startup, you can't help but get excited when Bob Kocher (Venrock) or Esther Dyson speak about the opportunities in healthcare given their impressive track records. Both spoke during this past week's StartUp Health Summit. One of Bob's main points was that the opportunity in healthcare is so big [...]
Health care is very much „in transition”. Have a quick look at the trends in health care 2014 . Now, try to predict what the outcomes will be of all these well intended developments? Due to changes in structure of processes, organizations, patients’ journeys, devices, drugs, apps, telemonitoring – health care will run the risk of becoming highly fragmented, maybe even chaotic. Let’s hope that professionals and their patients still do know their way around.
Can this be prevented? As costs will drive change for the coming years, I guess not. Health care is fundamentally being transformed. Why? Because it has been righteously disrupted and it will take time before a new satisfactory system has emerged. Do we need to wait for that? No! We have to see how we can construe things in a more informed perspective. ..
..there is a sure direction to give that constitutes the basic principle for moving forward: both because it is immanent to all needed developments to better care, and because it creates the opportunity to developments in oversee-able steps of change. Every party can draw its own choice on this to design a proper blue print to their process of change.
This principle directive is: Integrate, integrate, integrate.
Integration in care is about the unification of both parties and activities, aided by technology, devices, information and medications, to create better care for health and its outcomes. Integration will lead to better connections of different partners who are needed for a specific path or process of care. It will stimulate collaboration and coordination of activities between them. They will aim for better outcomes and higher effectiveness of care. It will lead to opportunities for more efficient arrangements of expertise and allocation of capacity of care givers. With the compound of the interests of the key players in care (and I mean of course, patients included), costs can be more rationally arranged and may lead to lowering prices of care per patient per year. Also, it will inspire higher transparency of processes and clarity to patients about details of the caring activities themselves.
There are three different kinds of integration. Each, open to start with. So, any party may pick and start its own game changer. Even any couple of parties as intended partners, may do so too. Choose the most easiest entry to your future development together and enjoy the ride!
1. Integration by Co-Operation 2. Integration by Co-Creation. 3. Integration by “Experience Co-Creation”.
The reputation of pharma companies remained at a low ebb last year, with performance ratings down across the board compared to 2011, according to a survey of patient groups.
All told, 35 per cent of respondents to the PatientView poll indicated that multinational pharma companies had an "excellent" or "good reputation", around the same as in 2012 but down from 41 per cent in 2011.
Once again, the drug industry ranked second bottom among healthcare industries just ahead of for-profit health insurers, while biotech companies also slipped down the rankings a little.
"Pharma should worry about patients' views of its corporate reputation," said Alex Wyke, PatientView's chief executive.
Good behavior is just the start of the corrective steps. Now we need to demonstrate our true commitment through providing real solutions to real problems, not just shiny bells! This is going to be hard for many Pharma marketers who still have a 6 month vision until the next big idea needs to be executed in panic mode!
he European Commission is today launching a consultation on #mHealth or mobile health, asking for help in finding ways to enhance the health and wellbeing of Europeans with the use of mobile devices, such as mobile phones, tablets, patient monitoring devices and other wireless devices.
In a recent post on Google+, the Glass team addressed the top 10 myths related to the futuristic augmented reality visor in an effort to simply "clear the air." Privacy concerning Glass is no doubt a hot topic as evident……
Social Media: A Review and Tutorial of Applications in Medicine and Health Care
Background: Social media are dynamic and interactive computer-mediated communication tools that have high penetration rates in the general population in high-income and middle-income countries. However, in medicine and health care, a large number of stakeholders (eg, clinicians, administrators, professional colleges, academic institutions, ministries of health, among others) are unaware of social media’s relevance, potential applications in their day-to-day activities, as well as the inherent risks and how these may be attenuated and mitigated. Objective: We conducted a narrative review with the aim to present case studies that illustrate how, where, and why social media are being used in the medical and health care sectors. Methods: Using a critical-interpretivist framework, we used qualitative methods to synthesize the impact and illustrate, explain, and provide contextual knowledge of the applications and potential implementations of social media in medicine and health care. Both traditional (eg, peer-reviewed) and nontraditional (eg, policies, case studies, and social media content) sources were used, in addition to an environmental scan (using Google and Bing Web searches) of resources. Results: We reviewed, evaluated, and synthesized 76 articles, 44 websites, and 11 policies/reports. Results and case studies are presented according to 10 different categories of social media: (1) blogs (eg, WordPress), (2) microblogs (eg, Twitter), (3) social networking sites (eg, Facebook), (4) professional networking sites (eg, LinkedIn, Sermo), (5) thematic networking sites (eg, 23andMe), (6) wikis (eg, Wikipedia), (7) mashups (eg, HealthMap), (8) collaborative filtering sites (eg, Digg), (9) media sharing sites (eg, YouTube, Slideshare), and others (eg, SecondLife). Four recommendations are provided and explained for stakeholders wishing to engage with social media while attenuating risk: (1) maintain professionalism at all times, (2) be authentic, have fun, and do not be afraid, (3) ask for help, and (4) focus, grab attention, and engage. Conclusions: The role of social media in the medical and health care sectors is far reaching, and many questions in terms of governance, ethics, professionalism, privacy, confidentiality, and information quality remain unanswered. By following the guidelines presented, professionals have a starting point to engage with social media in a safe and ethical manner. Future research will be required to understand the synergies between social media and evidence-based practice, as well as develop institutional policies that benefit patients, clinicians, public health practitioners, and industry alike.
(Phys.org) —Roughly 40 percent of all medications act on cells' G protein-coupled receptors (GPCRs). One of these receptors, beta 2 adrenergic receptor site (B2AR), naturally transforms between two base configurations; knowing the precise location of each of approximately 4,000 atoms is crucial for ...
Sven Awege's insight:
Boundaries blurring on all fronts. Pharma needs to partner more with different partners to the usual culprits, or get sidelined by alternative groupings.
U.S. Institute of Medicine white paper: Social Networking Sites and the Continuously Learning Health System: A Survey
Click here to edit the title
Sven Awege's insight:
KEY FINDINGS FROM THE SURVEYS
Sharing for care improvement: 94 percent of American social media users agree with sharing their health data to help doctors improve care.
· With appropriate anonymity, 94 percent of American social media users with a medical condition would be willing to share their health data to help doctors improve care. The same proportion (94 percent) would be willing to do this to help other patients like them.
Sharing for better evidence: 92 percent of American social media users with a medical condition agree with sharing their health data to help research.
· 92 percent of American social media users with a medical condition would be willing to anonymously share health data for researchers to learn more about their disease. 84 percent would be willing to share such information with drug companies to help them make safer products, and 78 percent would do so to let drug companies learn more about their disease.
Sharing to help others: 94 percent of American social media users agree with sharing their health data to help patients like themselves.
· 94 percent of American social media users believe that their health data should be used to improve the care of future patients who may have the same or similar condition.
Desire to share outweighs open questions: 76 percent of American social media users worry that health data they share may be used in detrimental ways.
· 76 percent of American social media users with a medical condition believe that data from their personal health records potentially could be used without their knowledge. 72 percent believe their data could be used to deny them health care benefits, and 66 percent believe it could be used to deny them job opportunities.
Prodeep Bose (who I can't find on Twitter, but anyway...) writes:
"The central crux of the FDA's ruling suggests that a company’s responsibility is for content posted and not the entirety of the social context. And the intent, if I were to derive one, is to enable—if not empower—pharma to engage in social marketing.
In fact, I would suggest that it is the responsibility of pharma to engage and dispel inaccuracies regarding its products with a genuine intent in doing just so, in a responsible manner. And I imagine that the positive thinker on either side of the regulatory fence, whether at FDA or pharma, would see eye to eye on furthering the goal of legitimate information dissemination through the most powerful means of communications in our time—social engagement."
Attitude and a real wish to make a difference - regulation is just an excuse. But... I would also challenge that perhaps social media is not always the channel to provide the biggest bang! Upstream clear thinking is critical, while panning for measurement will also ensure that we can build perenniality by demonstrating true engagement that matters on a scale that has impact.
The Digital age is forcing Healthcare Professionals to think beyond the traditional marketing ploys and to bridge the gap between patients, doctors and pharma companies by integrating Digital & Social Media. Experts from the industry have shared their views on how digital is going to be the next big thing in the Pharma Industry. This is a 2nd video from the series of videos taken from DigiSights 2013- India's 1st Digital Marketing Conference for Pharma & Healthcare organized by MediaMedic Communications.